SK Bioscience appoints Youngseok Kim as Head of Strategic Planning Office

Kim Young-seok, Head of Strategic Planning at SK Bioscience.

[Asia Economy Reporter Lee Gwan-joo] SK Bioscience announced on the 4th that it has recruited Kim Young-seok, a management strategy expert, as head of the Strategic Planning Office to execute new growth strategies aimed at securing global competitiveness.

Kim graduated from Seoul National University with a degree in Education and has accumulated diverse experience in areas such as business model development, business strategy and process enhancement, and management strategy consulting while serving as Director of the CRM division at global consulting firm Accenture, Asia Pacific PI Leader and Korea Digital Leader at EY Han Young.

As its next growth strategy, SK Bioscience plans to expand its scale through ▲ qualitative and quantitative expansion of R&D and production infrastructure ▲ acquisition of new platform technologies such as mRNA ▲ expansion of global networks ▲ external growth through M&A and JV establishment.

Additionally, the company will strengthen its vaccine portfolio by newly developing basic and premium vaccines and secure various product lines to prepare for the 'next pandemic.' At the same time, it will actively promote the 'glocalization (Global+localization)' project, which involves transferring vaccine production facilities to developing and underdeveloped countries.

SK Bioscience stated, "We expect to accelerate the execution of growth strategies based on the new executive's diverse practical experience and extensive network."

This content was produced with the assistance of AI translation services.